Article info

Download PDFPDF

Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Authors

  1. a 732-235-6807 howard.kaufman{at}rutgers.edu
  2. b Thomas.Amatruda{at}USONCOLOGY.COM
  3. c tonyreid{at}ucsd.edu
  4. d Rene.Gonzalez{at}ucdenver.edu
  5. e JGlaspy{at}mednet.ucla.edu
  6. f Eric.Whitman{at}atlantichealth.org
  7. g Kevin.Harrington{at}icr.ac.uk
  8. h JNemunaitis{at}MaryCrowley.Org
  9. i az255{at}cinj.rutgers.edu
  10. j wolfm{at}amgen.com
  11. k NSenzer{at}MaryCrowley.Org
View Full Text

Citation

Kaufman HL, Amatruda T, Reid T, et al
Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Publication history

  • Received December 20, 2015
  • Accepted February 4, 2016
  • First published March 15, 2016.
Online issue publication 
March 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.